Chumpitazi Bernabé F F, Flori Pierre, Kern Jean-Baptiste, Brenier-Pinchart Marie-Pierre, Larrat Sylvie, Minet Clémence, Bouillet Laurence, Maubon Danièle, Pelloux Hervé
Laboratory of Parasitology - Mycology, Grenoble University Hospital, CS 10217, F-38043 Grenoble, France.
Laboratory of Parasitology - Mycology, University Hospital of Saint Etienne, Saint Etienne, Av Albert Raimond, F-42055 Saint Etienne, France.
JMM Case Rep. 2014 Dec 1;1(4):e003434. doi: 10.1099/jmmcr.0.T00017. eCollection 2014 Dec.
When diagnosing pneumonia (PJP), the clinical suspicion must be confirmed by laboratory tests. PJP is rarely described in patients with idiopathic CD4 lymphocytopenia (ICL), a rare T-cell deficiency of unknown origin with persistently low levels of CD4 T-cells (<300 µl or <20 % of total lymphocytes) but repeated negative human immunodeficiency virus (HIV) tests. We retrospectively analysed a case of an ICL patient with severe PJP associated with multiple opportunistic infections (OIs). We also reviewed the literature since 1986.
A laboratory-confirmed case of PJP associated with invasive candidiasis and cytomegalovirus infection was reported in an ICL patient. Despite early treatment, the patient died of respiratory failure under polymicrobial pneumonia. According to the literature, the mortality rate of ICL patients is 10.4 % (33/316). In ICL patients, the risk of OI is 83.2 % (263/316), with viral infections being the most prevalent (58.2 %, 184/316), followed by fungal infections (52.2 %, 165/316) and mycobacterial infections (15.5 %, 49/316). Dysimmunity is reported in 15.5 % (49/316) of ICL patients. Among the fungal infections, cryptococcal infections are the most prevalent (24.1 %, 76/316), followed by candidiasis (15.5 %, 49/316) and PJP (7.9 %, 25/316).
The high risk of OIs underlines the importance of more vigorous preventative actions in hospitals. The response to therapy and the detection of early relapse of PJP may be monitored by several laboratory tests including quantitative PCR. It is essential to treat the ICL and to follow the guidelines concerning therapy and prophylaxis of OIs as given to HIV patients.
诊断肺孢子菌肺炎(PJP)时,临床怀疑必须通过实验室检查来证实。PJP在特发性CD4淋巴细胞减少症(ICL)患者中很少被描述,ICL是一种罕见的、病因不明的T细胞缺陷,CD4 T细胞水平持续较低(<300 μl或<总淋巴细胞的20%),但人类免疫缺陷病毒(HIV)检测反复呈阴性。我们回顾性分析了1例患有严重PJP并伴有多种机会性感染(OI)的ICL患者的病例。我们还回顾了自1986年以来的文献。
1例ICL患者报告了1例经实验室确诊的PJP,伴有侵袭性念珠菌病和巨细胞病毒感染。尽管进行了早期治疗,但患者死于多重微生物肺炎导致的呼吸衰竭。根据文献,ICL患者的死亡率为10.4%(33/316)。在ICL患者中,OI的风险为83.2%(263/316),其中病毒感染最为常见(58.2%,184/316),其次是真菌感染(52.2%,165/316)和分枝杆菌感染(15.5%,49/316)。15.5%(49/316)的ICL患者报告有免疫失调。在真菌感染中,隐球菌感染最为常见(24.1%,76/316),其次是念珠菌病(15.5%,49/316)和PJP(7.9%,2)。
OI的高风险凸显了医院采取更积极预防措施的重要性。对PJP治疗的反应和早期复发的检测可通过包括定量PCR在内的多项实验室检查进行监测。治疗ICL并遵循给予HIV患者的OI治疗和预防指南至关重要。 5/316)。
OI的高风险凸显了医院采取更积极预防措施的重要性。对PJP治疗的反应和早期复发的检测可通过包括定量PCR在内的多项实验室检查进行监测。治疗ICL并遵循给予HIV患者的OI治疗和预防指南至关重要。